ArticleFrontiers in microbiology2026
Modulation of LPS-associated virulence activity for reduction of periodontal inflammatory burden.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning Stratification of Periodontal and Cerebrovascular Disease Status Using Salivary and Subgingival Lipopolysaccharide Activity.Journal of cellular and molecular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dysbiotic oral biofilms produce virulence factors, such as lipopolysaccharide (LPS), triggering and sustaining chronic inflammation in periodontal tissues. Modulation of the bioactivity of these products offers a potential novel, adjunctive approach beyond conventional periodontal therapy. Methods: Pooled saliva and subgingival biofilm samples from 324 healthy, gingivitis, and periodontitis participants were assessed for endotoxin activity using the recombinant Factor C (rFC) assay. Functional immune-stimulation was evaluated in THP-1 and THP-1 Dual cell models through NF-κB and IRF pathways activation assessment and cytokine profiling. The modulatory effects of antimicrobial peptide LL-37 and the LPS-binding compound Polymyxin B on saliva and subgingival biofilm inflammatory potential were assessed in the same models. Results: Recombinant Factor C assays demonstrated marked reductions in endotoxin activity of saliva and subgingival biofilms treated with LL-37 and Polymyxin B (>90% reduction). Both NF-κB and IRF signaling were broadly attenuated following modulation, with polymyxin B exerting greater suppression of NF-κB activity, while LL-37 showed stronger inhibition of IRF, particularly in salivary samples. Pro-inflammatory cytokines secretion by THP-1 cells (IL-1β, IL-6, IL-8, and TNF-α) challenged with bio-modulated samples decreased by 40-75% compared to untreated samples. Interestingly, anti-inflammatory cytokines such as TGF-β and IL-10 remained largely unchanged, suggesting selective suppression of the cytokine cascade. Conclusion: Modulating LPS-associated virulence activity substantially reduces the inflammatory potential of saliva and subgingival plaque. LL-37 and Polymyxin B illustrate complementary strategies for LPS modulations and highlight the feasibility of their use as adjunctive approaches for the prevention and treatment of periodontal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.